Zydus Lifesciences’ Q1 FY26 earnings show modest growth, but beneath the surface lies a …
Medicamen Biotech just released its Q1 FY25 results, showing a stark swing from profit to …
Concord Biotech’s Q1FY26 results presented a puzzling dip in revenue and EBITDA. Is this cause …